BIOMAT Database Logo BIOMAT Database Logo

Clinical usefulness of FDG-PET for management of well-differentiated digestive neuroendocrine tumors. 2020

Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
Department of Hepato-Gastroenterology and Digestive Oncology, Robert-Debré University Hospital, Reims Cedex, France.

UI MeSH Term Description Entries
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission
D018358 Neuroendocrine Tumors Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition. Neuroendocrine Tumor,Tumor, Neuroendocrine,Tumors, Neuroendocrine
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical
D019788 Fluorodeoxyglucose F18 The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162) 18F Fluorodeoxyglucose,18FDG,2-Fluoro-2-deoxy-D-glucose,2-Fluoro-2-deoxyglucose,Fludeoxyglucose F 18,18F-FDG,Fluorine-18-fluorodeoxyglucose,Fluorodeoxyglucose F 18,2 Fluoro 2 deoxy D glucose,2 Fluoro 2 deoxyglucose,F 18, Fludeoxyglucose,F 18, Fluorodeoxyglucose,F18, Fluorodeoxyglucose,Fluorine 18 fluorodeoxyglucose,Fluorodeoxyglucose, 18F

Related Publications

Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
Management of well-differentiated neuroendocrine tumors.
September 2021, Clinical advances in hematology & oncology : H&O,
Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions.
May 2021, Cancers,
Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
[Well-differentiated neuroendocrine tumors of the digestive tract: Focus on pancreatic neuroendocrine tumors].
September 2023, Bulletin du cancer,
Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
Clinical usefulness of FDG PET in differentiated thyroid cancer.
January 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review.
June 2023, Nuclear medicine communications,
Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
Consensus guidelines for the management of patients with digestive neuroendocrine tumors--well-differentiated jejunal-ileal tumor/carcinoma.
January 2008, Neuroendocrinology,
Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
Management of Well-Differentiated High-Grade (G3) Neuroendocrine Tumors.
August 2019, Current treatment options in oncology,
Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients.
March 2018, The clinical respiratory journal,
Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
[Neuroendocrine well-differentiated pancreatic tumors].
April 2015, La Revue du praticien,
Marine Perrier, and Olivia Hentic, and Thomas Walter, and Christine Do Cao, and Guillaume Cadiot, and Louis de Mestier, and
Current clinical trials of targeted agents for well-differentiated neuroendocrine tumors.
November 2014, Pancreas,
Copied contents to your clipboard!